Effects of cinacalcet on achieving the targets listed in the guidelines of the Japanese Society for Dialysis Therapy
-
- Arimura Tetsuro
- Social Insurance Shiga Hospital
-
- Isono Motohide
- Otsu Municipal Hospital
-
- Ohhashi Seiji
- Ohhashi Renal Dialysis Clinic
-
- Kondoh Morihiro
- Rakuwakai Otowa Memorial Hospital
-
- Shikano Tsutomu
- The Second Okamoto General Hospital
-
- Tomita Kohbin
- Tomita Clinic
-
- Nishio Toshiji
- Seta Clinic
-
- Nishimura Masataka
- Nagahama City Hospital
-
- Hatta Tsuguru
- Omihachimann Community Medical Center
-
- Nishio Toshiki
- Saiseikai Shigaken Hospital
-
- Nagasaku Daisuke
- Yujin Yamasaki Hospital
-
- Kume Shinji
- Shiga University of Medical Science
-
- Isshiki Keiji
- Shiga University of Medical Science
-
- Uzu Takashi
- Shiga University of Medical Science
Bibliographic Information
- Other Title
-
- 慢性血液透析患者におけるシナカルセトのJSDTガイドライン達成率への影響 ‐びわこ臨床透析カンファレンス共同研究‐
- 慢性血液透析患者におけるシナカルセトのJSDTガイドライン達成率への影響--びわこ臨床透析カンファレンス共同研究
- マンセイ ケツエキ トウセキ カンジャ ニ オケル シナカルセト ノ JSDT ガイドライン タッセイリツ エ ノ エイキョウ ビワコリンショウ トウセキ カンファレンス キョウドウ ケンキュウ
- ―びわこ臨床透析カンファレンス共同研究―
Search this article
Abstract
Aim : We evaluated the impact of cinacalcet on achieving the targets listed in the guidelines of the Japanese Society for Dialysis Therapy (JSDT) [phosphate (P) 3.5~6.0 mg/dL, corrected calcium (Ca) 8.4~10.0 mg/dL and intact parathyroid hormone (iPTH) 60~180 pg/mL]. Patients and methods : We examined the medical records of 52 hemodialyzed Japanese patients who were treated with cinacalcet between January and December 2008. Cinacalcet was discontinued in 5 patients due to adverse effects and iPTH levels were not followed in 1 patient. Therefore, we analyzed data from 46 patients. Results : During the follow-up periods, 24 patients achieved iPTH levels within the target range and 19 patients achieved the target ranges for P, Ca and iPTH (group A). Baseline iPTH levels were significantly different between group A and patients who did not achieve the target levels of P, Ca or iPTH (group NA) (353±124 pg/mL vs. 668±383 pg/mL, p<0.01). The baseline Ca level was also significantly lower in group A than in group NA. Of patients with baseline intact PTH level≤500 pg/mL, 78% achieved the target iPTH level and 63% were classified into group A. Of patients with baseline iPTH>500 pg/mL, 16% achieved the target iPTH level and 11% were classified into group A. Parathyroid gland size, which was measured by ultrasonography in 5 patients, was significantly reduced from the baseline to week 24 (580±349 mm3 vs. 357±254 mm3, p=0.03). Conclusion : The presence of a low iPTH level (180~500 pg/mL) without elevated Ca level predicts a good response to cinacalcet. Cinacalcet may also be effective in patients with enlarged parathyroid glands.
Journal
-
- Nihon Toseki Igakkai Zasshi
-
Nihon Toseki Igakkai Zasshi 43 (9), 787-794, 2010
The Japanese Society for Dialysis Therapy
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390001204679852672
-
- NII Article ID
- 130000431890
- 40017331065
-
- NII Book ID
- AN10432053
-
- ISSN
- 1883082X
- 13403451
-
- NDL BIB ID
- 10849276
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- NDL
- Crossref
- CiNii Articles
-
- Abstract License Flag
- Disallowed